Literature DB >> 9579570

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.

V af Geijersstam1, Z Wang, I Lewensohn-Fuchs, C Eklund, J T Schiller, M Forsgren, J Dillner.   

Abstract

To assess long-term trends in the prevalence of oncogenic human papillomavirus (HPV) infection, we performed a cross-sectional serosurvey of the seroprevalence of the major oncogenic HPV type, HPV16, among 3,512 pregnant women undergoing population-based serological screening at the first trimester of pregnancy in the same catchment area in Stockholm, Sweden, during 1969, 1983 or 1989. The overall HPV16 seroprevalence rates were 16% in 1969, 22% in 1983 and 21% in 1989. Seroprevalence was significantly increased, comparing both 1969 vs. 1983 (p = 0.0005) and 1969 vs. 1989 (p = 0.008). By comparison, the previously reported herpes simplex 2 (HSV-2) seroprevalence in the same women increased from 17% in 1969 to 32% in 1983 and 33% in 1989, whereas the seroprevalence rates of HSV-1 were the same (69% in 1969, 63% in 1983 and 68% in 1989). Odds ratios for HPV 16-positive women to also be HSV-2-positive were 1.8 in 1969 (p < 0.005), 1.1 in 1983 (p = NS) and 1.0 in 1989. Our results suggest that both HSV-2 and HPV16 became more generally spread in the Swedish population between 1969 and 1983 but that the spread has been stable during the 1980s.

Entities:  

Mesh:

Year:  1998        PMID: 9579570     DOI: 10.1002/(sici)1097-0215(19980504)76:3<341::aid-ijc10>3.0.co;2-e

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Sexual behaviour and early coitarche in a national sample of 17 year old Swedish girls.

Authors:  K Edgardh
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

2.  Adolescent sexual health in Sweden.

Authors:  K Edgardh
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

3.  Knowledge about the prevention of sexually transmitted diseases: a longitudinal study of young women from 16-23 years of age.

Authors:  A Andersson-Ellström; I Milsom
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

Review 4.  Clinical implications of human papillomavirus in head and neck cancers.

Authors:  Carole Fakhry; Maura L Gillison
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

5.  Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.

Authors:  Staffan Görander; Teresa Lagergård; Malgorzata Romanik; Raphael P Viscidi; Gayane Martirosian; Jan-Ake Liljeqvist
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

Review 6.  The burden of HPV-associated anogenital cancers.

Authors:  Katie Wakeham; Kimberley Kavanagh
Journal:  Curr Oncol Rep       Date:  2014-09       Impact factor: 5.945

7.  Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx.

Authors:  Guojun Li; Zhigang Huang; Xingming Chen; Qingyi Wei
Journal:  J Biomed Res       Date:  2010-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.